Form 4: Vita Coco CFO Sells Shares Under 10b5-1 Plan

Corey Baker, CFO of Vita Coco Company, Inc., reported multiple transactions involving the sale of common stock and exercise of options under a pre-arranged 10b5-1 trading plan.

Summary

• Corey Baker, Chief Financial Officer of Vita Coco Company, Inc. (COCO), reported a series of equity transactions between September 11 and September 15, 2025.
• Transactions included the sale of 3,000 shares of common stock at prices ranging from $38.66 to $40.00.
• Baker also exercised 2,000 non-qualified stock options at an exercise price of $16.91, converting them into common stock.
• All sales of common stock were executed pursuant to a pre-arranged Rule 10b5-1 trading plan.
• Following these transactions, Baker's direct beneficial ownership of common stock is 38,754 shares.
• Remaining derivative holdings include 12,205 non-qualified stock options exercisable at $16.91, and additional options with exercise prices ranging from $24.35 to $33.36, subject to various vesting schedules.

Sentiment

Score: 5

Explanation: The transactions are routine insider sales and option exercises executed under a pre-arranged 10b5-1 trading plan, which typically mitigates negative sentiment associated with insider selling. The net change in direct ownership is minor.

Positives

• The sales of common stock were executed under a Rule 10b5-1 trading plan, indicating these were pre-scheduled transactions rather than a reaction to recent company performance or market conditions.
• The exercise of stock options at $16.91 allowed the CFO to acquire shares at a significantly lower price than the market sale prices of $38.66 and $40.00, demonstrating a profitable conversion of equity incentives.

Negatives

• The net effect of the reported transactions is a reduction in the direct beneficial ownership of common stock by the Chief Financial Officer, from an initial 39,754 shares (after the first option exercise) to 38,754 shares.
• Insider selling, even if pre-planned, can sometimes be perceived by the market as a lack of conviction, though the 10b5-1 plan mitigates this.

Risks

• No specific risks related to the company's operations or financial health are mentioned in this transactional filing.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Management Comments

• The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
• Stock options vest in various annual installments, contingent on continuous service.

Industry Context

This filing is a routine insider transaction report and does not provide information directly related to broader industry trends or competitive landscape.

Comparison to Industry Standards

• NA

Stakeholder Impact

• Shareholders may observe a slight reduction in the Chief Financial Officer's direct common stock holdings, though mitigated by the 10b5-1 plan.

Next Steps

• Continued vesting of non-qualified stock options on March 10, 2025, March 10, 2026, and March 10, 2027, for options with exercise prices of $24.35 and $27.59.
• Continued vesting of non-qualified stock options in four equal annual installments beginning March 4, 2025, for options with an exercise price of $26.18.
• Continued vesting of non-qualified stock options in four equal annual installments on each anniversary of the grant date for options with an exercise price of $33.36, provided continuous service.

Key Dates

Recommendation

The reported transactions are routine insider sales and option exercises executed under a pre-arranged Rule 10b5-1 trading plan. Such pre-planned sales do not typically signal a change in management's outlook on the company's future performance, thus a 'hold' recommendation is appropriate based solely on this filing.

Keywords

Vita Coco, COCO, Corey Baker, CFO, Insider Trading, Form 4, Stock Options, 10b5-1 Plan, Equity Sales, Beneficial Ownership